Local agricultural giant JBS United changing its name
One of the Indianapolis-area’s largest private companies is taking on a different name to better reflect its mission in livestock health.
One of the Indianapolis-area’s largest private companies is taking on a different name to better reflect its mission in livestock health.
The 2.3 percent federal excise tax on medical device manufacturers originally imposed in 2013 as one of several taxes and fees in the Affordable Care Act
The 5-year-old Carmel biotech has won plenty of attention from Wall Street and has secured more than $100 million through licensing deals and a stock offering to help fund expensive clinical trials.
Hill-Rom Holdings Inc., which owns Tridien Medical, said it plans to begin eliminating employees Jan. 31 with terminations continuing until Sept. 30, when the facility will permanently close.
A company founded a year ago by prominent local tech entrepreneur Don Brown expects to pay average salaries of $156,000 a year in new space at the IU Emerging Technology Center.
The suit names two dozen entities, including Stamford, Connecticut-based Purdue Pharma LP—which produces OxyContin—as well as Cephalon Inc, Teva Pharmaceutical Industries Ltd., Johnson & Johnson and Janssen Pharmaceuticals.
AgriNovus Indiana wants to get the word out on the state’s agbiosciences efforts and the opportunities they offer across several agricultural and technological sectors.
The company said the funds would help it test its lead compound in late-stage clinical trials, allowing surgeons to detect cancerous cells with the help of fluorescent dyes.
The Carmel-based company makes a device that uses sound waves to help position and monitor breathing tubes for newborns in hospitals.
The startup, founded by serial entrepreneur Don Brown, has hashed out a deal that it gives it access to a broad range of intellectual property.
Cook officials cast the sale of Cook Pharmica and the purchase of what once was the world’s largest refrigerator factory as good news for Bloomington.
The Greenfield-based unit, which makes a vast array of vaccines, antibiotics, feed additives and other health products for livestock and pets, is in a slump, after more than a decade of growth.
David Broecker was founding CEO of the four-year-old Indiana Biosciences Research Institute, which aims to bridge the gap between research universities and industry in life sciences.
Whether so-called micro-hospitals can succeed financially might depend on whether they can meet Medicare’s definition of a hospital: a medical facility that dedicates the bulk of its services to inpatient care.
DuPont and Dow Chemical Co. say they have cleared all regulatory hurdles and will complete their planned merger at the end of the month.
DuPont Co. saw seed sales rise in the second quarter—good news before it closes in on the historic $75 billion merger with Dow Chemical Co., the parent of Indianapolis-based Dow AgroSciences.
The grant from the Indianapolis-based philanthropic giant is aimed at bolstering Indiana’s stature as a life sciences research hub.
The 16 Tech innovation district, an ambitious economic development project in the works in Indianapolis for more than a decade, has hired a top executive whose goal is to turn the downtrodden area into a thriving center for entrepreneurship and innovation.
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
Bio-Response Solution’s flagship product liquefies human corpses, turning muscle, flesh and fat into a coffee-colored effluent that can be swirled down the drain.